2012
Children's Oncology Group's 2013 blueprint for research: Rare tumors
Rodriguez‐Galindo C, Krailo M, Frazier L, Chintagumpala M, Amatruda J, Katzenstein H, Malogolowkin M, Spector L, Pashankar F, Meyers R, Tomlinson G, Committee O. Children's Oncology Group's 2013 blueprint for research: Rare tumors. Pediatric Blood & Cancer 2012, 60: 1016-1021. PMID: 23255219, PMCID: PMC4304764, DOI: 10.1002/pbc.24428.Peer-Reviewed Original ResearchConceptsGerm cell tumorsCell tumorsRare cancersChildren's Oncology Group's 2013 blueprintInternational phase 3 clinical trialsPhase 3 clinical trialsEvidence-based definitionIntraocular retinoblastomaAdvanced carcinomaRisk stratificationInfrequent malignancyRare tumorClinical trialsClinical studiesLiver tumorsTumorsBiologic studiesChildrenCancerRetinoblastomaCarcinomaMalignancyHepatoblastomaYearsTrials
2005
Atrial fibrillation: How to approach rate control
Rosenfeld LE. Atrial fibrillation: How to approach rate control. Current Cardiology Reports 2005, 7: 391-397. PMID: 16105496, DOI: 10.1007/s11886-005-0094-3.Commentaries, Editorials and LettersConceptsPrevention of tachycardiaRhythm control strategyMinority of patientsCalcium channel blockersReduction of symptomsUse of therapiesEvidence-based definitionConsiderable clinical importanceNodal ablationAtrial fibrillationSerial assessmentNovel therapiesChannel blockersΒ-blockersHeart rateClinical importanceOptimal managementTherapySymptomsRate controlTachycardiaPatientsCardiomyopathyFibrillationBlockers
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply